Erratum

Errata

This article corrects:

  1. Is routine cervical dilatation necessary during elective caesarean section? A randomised controlled trial Volume 49, Issue 3, 263–267, Article first published online: 15 June 2009

The publisher would like to draw attention to errors in the following article:

Güngördük K, Yildirim G, Ark C. Is routine cervical dilatation necessary during elective caesarean section? A randomised controlled trial. Aust N Z J Obstet Gynaecol 2009 49: 263–267. DOI: 10.1111/j.1479-828X.2009.00980.x

Tables 1 and 2 were presented incorrectly. The correct tables are shown below.

The publisher apologizes for these errors and any confusion it may have caused.

Table 1.  Demographic characteristics of the study groups
 Group A
(n = 200)
Group B
(n = 200)
  • Data are presented as mean ± standard deviation (SD).

Age ± SD (year)26.52 ± 4.2627.69 ± 4.14
Parity (n, %)19 (9.5%)8 (4.0%)
0  
≥ 1181 (90.5%)192 (96%)
Gestational age at delivery ± SD (weeks)38.14 ± 0.7438.19 ± 0.42
Body mass index ± SD (kg/m2) 31.60 ± 3.0932.12 ± 2.67
Preoperative hematocrit level ± SD (%)33.20 ± 1.4433.45 ± 1.15
Preoperative haemoglobin level ± SD (g/L)11.51 ± 0.8011.36 ± 0.66
Preoperative temperature ± SD (°C) 36.66 ± 0.20 36.67 ± 0.22
Caesarean indications: (n, %)
 Previous caesarean delivery < 2158 (79%)175 (87.5%)
 Previous caesarean delivery ≥ 222 (11%)17 (8.5%)
 Fetal macrosomia (≥ 4500 g)8 (4%)4 (2%)
 Breech presentation8 (4%)2 (1%)
 Transverse lie4 (2%)2 (1%)
Table 2.  Study outcomes
 Group A (n = 200)Group B (n = 200)P-valueRelative risk (95% CI)
  1. †Data are presented as mean ± standard deviation (SD). CI, confidence interval.

Postoperative hematocrit level ± SD (%) 30.05 ± 1.17 30.04 ± 0.74 0.91 
Postperative haemoglobin level ± SD (g/L)9.77 ± 0.70 9.83 ± 0.45 0.37 
Estimated blood loss ± SD (mL)645.58 ± 232.04 693.49 ± 174.78 0.20 
Hospital stay ± SD (days)2.26 ± 0.84 2.17 ± 0.78 0.24 
Operative time ± SD (min)36.91 ± 2.47 38.75 ± 1.07 0.00 
Infectious morbidity20 (10%) 22 (11%) 0.871.11 (0.58–2.11)
Febrile morbidity10 (5%) 12 (6%) 0.661.21 (0.51–2.87)
Wound infection9 (4.5%) 10 (5%) 0.821.11 (0.44–2.81)
Endometritis3 (1.5%) 5 (2.5%) 0.721.68 (0.39–7.14)
Urinary tract infection5 (2.5%) 5 (2.5%) 1.001.00 (0.28–3.50)

Ancillary